EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study

Xinyu Qi, Maoxing Liu, Kai Xu, Fei Tan, Pin Gao, Zhendan Yao, Nan Zhang, Hong Yang, Chenghai Zhang, Jiadi Xing, Ming Cui, Xiangqian Su iD

Surgical Endoscopy · 2024

DOI: 10.1007/s00464-024-10875-y ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Surgical Endoscopy, 2024. Verfasst von Xinyu Qi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery IV, Peking University Can…. Hauptthemen laut MEDLINE: Esophagogastric Junction, Adenocarcinoma, Lymphatic Metastasis, Stomach Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

No consensus has been concluded with regarding to the scope of lymph node (LN) dissection for Siewert type II and III adenocarcinoma of the esophagogastric junction (AEG). This study aimed to explore risk factors for lower perigastric LN (LPLN) metastases (including no. 4d, 5, 6, and 12a LN stations) and analyze the indications for LPLN dissection.

Methods

In total, 302 consecutive patients with Siewert type II and III AEG who underwent total gastrectomy (TG) were enrolled. The logistic regression model was used to perform uni- and multivariate analyses of risk factors for LPLN metastases. Kaplan–Meier curves were used for survival analysis, and log-rank tests were used for group comparisons. Basing on the guidelines of Japanese Gastric Cancer Association, the LN metastases (LNM) as well as the efficiency index (EI) of each LN station was further evaluated.

Results

The independent risk factors for LPLN metastases in patients with Siewert type II and III AEG were distance from the esophagogastric junction (EGJ) to the distal end of the tumor (> 4.0 cm), preoperative carcinoembryonic antigen (CEA) ( +), pT4 stage, and HER-2 ( +). LPLN metastases was an independent risk factor for overall survival following TG. The LNM and EI of LPLN were 8.6% and 2.31%, respectively. The LNM of LPLN > 10% under the stratification of the distance from the EGJ to the distal end of the tumor (> 4.0 cm), pT4, preoperative CEA ( +), and HER-2 ( +) exhibited EI values of 3.55%, 2.09%, 2.51%, and 3.64%, respectively.

Conclusions

LPLN metastases was a malignant factor for the prognosis of patients with Siewert type II and III AEG. For patients with preoperative CEA ( +), pT4 stage, HER-2 ( +), and the distance from the EGJ to the distal end of the tumor (> 4.0 cm), TG with LPLN dissection is prioritized for clinical recommendation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophagogastric JunctionAdenocarcinomaLymphatic MetastasisStomach NeoplasmsGastrectomyLymph Node ExcisionEsophageal NeoplasmsHumansMaleFemaleRetrospective StudiesMiddle AgedRisk FactorsAgedAdultLymph NodesClinical Relevance

Stichwörter der Autor:innen

Efficacy indexLower perigastric lymph nodeLymph node metastasesRisk factors

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery IV, Peking University Cancer Hospital & Institute, Beijing, 100142, People's Republic of China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery IV, Peking University Cancer Hospital & Institute, Beijing, 100142, People's Republic of China.…
  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Surgery IV, Peking University Canc…

ORCID-Profile: Xiangqian Su

Förderung

  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation
  • Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support
  • Clinical Research Fund For Distinguished Young Scholars of Beijing Cancer Hospital

Zitieren

APA

Qi, X., Liu, M., Xu, K., Tan, F., Gao, P., Yao, Z., Zhang, N., Yang, H., Zhang, C., Xing, J., Cui, M., & Su, X. (2024). Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-10875-y

Vancouver

Qi X, Liu M, Xu K, Tan F, Gao P, Yao Z, et al. Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study. Surgical Endoscopy. 2024. doi:10.1007/s00464-024-10875-y

BibTeX
@article{Qi2024,
  author = {Qi, Xinyu and Liu, Maoxing and Xu, Kai and Tan, Fei and Gao, Pin and Yao, Zhendan and Zhang, Nan and Yang, Hong and Zhang, Chenghai and Xing, Jiadi and Cui, Ming and Su, Xiangqian},
  title = {Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study},
  journal = {Surgical Endoscopy},
  year = {2024},
  doi = {10.1007/s00464-024-10875-y}
}
Kostenlos starten →